{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20250204",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "80972",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/209299Orig1s003ltr.pdf",
              "date": "20250206",
              "type": "Letter"
            },
            {
              "id": "80975",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209299Orig1s003lbl.pdf",
              "date": "20250206",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20180417",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "53706",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209299lbl.pdf",
              "date": "20180417",
              "type": "Label"
            },
            {
              "id": "53711",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/209299Orig1s000ltr.pdf",
              "date": "20180417",
              "type": "Letter"
            },
            {
              "id": "54188",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/209299Orig1s000TOC.html",
              "date": "20180515",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA209299",
      "sponsor_name": "RIGEL PHARMS",
      "openfda": {
        "application_number": [
          "NDA209299"
        ],
        "brand_name": [
          "TAVALISSE"
        ],
        "generic_name": [
          "FOSTAMATINIB"
        ],
        "manufacturer_name": [
          "Rigel Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "71332-001",
          "71332-002"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "FOSTAMATINIB"
        ],
        "rxcui": [
          "2044922",
          "2044928",
          "2044930",
          "2044932"
        ],
        "spl_id": [
          "78828503-b88f-4e3d-9add-8b738c4cf28e"
        ],
        "spl_set_id": [
          "21149cc3-049b-43e2-b141-c9499160556c"
        ],
        "package_ndc": [
          "71332-001-01",
          "71332-002-01"
        ],
        "unii": [
          "SQ8A3S5101"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "TAVALISSE",
          "active_ingredients": [
            {
              "name": "FOSTAMATINIB DISODIUM",
              "strength": "EQ 100MG BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        },
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "TAVALISSE",
          "active_ingredients": [
            {
              "name": "FOSTAMATINIB DISODIUM",
              "strength": "EQ 150MG BASE"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        }
      ]
    }
  ]
}